July 1 (Reuters) - The U.S. Federal Trade Commission has opened an investigation into Teva Pharmaceuticals over the company's refusal to take down about two dozen patents for its asthma and COPD inhalers, the Washington Post reported on Monday citing agency documents. (Reporting by Gursimran Kaur in Bengaluru; Editing by Saumyadeb Chakrabarty)